JZP-458 (RC-P)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JZP-458 (RC-P), covering 2023-11-18 to 2023-11-18. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) [Phase 2, Phase 3]